Brief: BioSenic Appoints Michel Wurm As Interim Medical Director
Dec 2 (Reuters) - BIOSENIC BIOS.BR :
* BIOSENIC APPOINTS MICHEL WURM, MD, AS MEDICAL DIRECTOR
* APPOINTMENT OF DR. MICHEL WURM AS INTERIM MEDICAL DIRECTOR
WHO
WILL BE RESPONSIBLE FOR DEVELOPMENT OF GROUP'S TWO CELL THERAPY,
AUTOIMMUNE DISEASE PLATFORMS
* MICHEL WURM WILL HOLD OFFICE UNTIL BIOSENIC SELECTS A
PERMANENT
MEDICAL DIRECTOR
Source text for Eikon: ID:nGNE7j5QTm
Further company coverage: BIOS.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd